Investigations on aberrant glycosylation of glycosphingolipids in colorectal cancer tissues using liquid chromatography and matrix-assisted laser desorption time-of- flight mass spectrometry (MALDI-TOF-MS)

Molecular and Cellular Proteomics

Volumn 12, Issue 11, 2013, Pages 3081-3093

  Holst, Stephanie ^a   Stavenhagen, Kathrin ^a   Balog, Crina I A ^a   Koeleman, Carolien A M ^a   McDonnell, Liam M ^a   Mayboroda, Oleg A ^a   Verhoeven, Aswin ^a   Mesker, Wilma E ^a   Tollenaar, Rob A E M ^a   Deelder, André M ^a   Wuhrer, Manfred ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRANILIC ACID; GANGLIOSIDE; GLYCAN; GLYCOSPHINGOLIPID;

ACETYLATION; ARTICLE; CANCER TISSUE; COLORECTAL CANCER; CONTROLLED STUDY; FUCOSYLATION; GLYCOSYLATION; HUMAN; HUMAN CELL; HYDROPHILIC INTERACTION CHROMATOGRAPHY; LIQUID CHROMATOGRAPHY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SULFATION;

ADULT; AGED; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; FEMALE; GLYCOSPHINGOLIPIDS; GLYCOSYLATION; HUMANS; MALE; METABOLOME; MIDDLE AGED; MOLECULAR STRUCTURE; MULTIVARIATE ANALYSIS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TANDEM MASS SPECTROMETRY; TUMOR MARKERS, BIOLOGICAL;

EID: 84887053047     PISSN: 15359476     EISSN: 15359484     Source Type: Journal    
DOI: 10.1074/mcp.M113.030387     Document Type: Article

References (67)

1. Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., and Forman, D. (2011) Global cancer statistics. Cancer J. Clin. 61, 69-90.
2. Weitz, J., Koch, M., Debus, J., Höhler, T., Galle, P. R., and Bü chler, M. W. (2005) Colorectal cancer. Lancet 365, 153-165. (Pubitemid 40091806)
3. Davies, R. J., Miller, R., and Coleman, N. (2005) Colorectal cancer screening: prospects for molecular stool analysis. Nat. Rev. Cancer 5, 199-209. (Pubitemid 40314951)
4. Wolpin, B. M., and Mayer, R. J. (2008). Systemic treatment of colorectal cancer. Gastroenterology 134, 1296-1310.e1.
5. Murata, K., Miyoshi, E., Kameyama, M., Ishikawa, O., Kabuto, T., Sasaki, Y., Hiratsuka, M., Ohigashi, H., Ishiguro, S., Ito, S., Honda, H., Takemura, F., Taniguchi, N., and Imaoka, S. (2000) Expression of n- acetylglucosaminyltransferase V in colorectal cancer correlates with metastasis and poor prognosis. Clin. Cancer Res. 6, 1772-1777. (Pubitemid 30305070)
6. Diaz-Cano, S. J. (2012) Tumor heterogeneity: mechanisms and bases for a reliable application of molecular marker design. Int. J. Mol. Sci. 13, 1951-2011.
7. An, H. J., Kronewitter, S. R., Leoz, M. L. A. de, and Lebrilla, C. B. (2009). Glycomics and disease markers. Curr. Opin. Chem. Biol. 13:601-607.
8. Kannagi, R., Izawa, M., Koike, T., Miyazaki, K., and Kimura, N. (2004) Carbohydrate-mediated cell adhesion in cancer metastasis and angiogenesis. Cancer Sci. 95, 377-384. (Pubitemid 38832679)
9. Hakomori, S. (1996) Tumor Malignancy Defined by Aberrant Glycosylation and Sphingo(glyco)lipid Metabolism. Cancer Res. 56, 5309-5318. (Pubitemid 27011703)
10. Fernandes, B., Sagman, U., Auger, M., Demetrio, M., and Dennis, J. W. (1991) β1-6 branched oligosaccharides as a marker of tumor progression in human breast and colon neoplasia. Cancer Res. 51, 718-723.
11. Brockhausen, I. (2006) Mucin-type O-glycans in human colon and breast cancer: glycodynamics and functions. EMBO Rep. 7, 599-604. (Pubitemid 43827326)
12. Regina Todeschini, A., and Hakomori, S. (2008) Functional role of glycosphingolipids and gangliosides in control of cell adhesion, motility, and growth, through glycosynaptic microdomains. Biochim. Biophys. Acta, Gen. Subj. 1780, 421-433. (Pubitemid 351381254)
13. Durrant, L. G., Noble, P., and Spendlove, I. (2012) Immunology in the clinic review series; focus on cancer: glycolipids as targets for tumour immunotherapy. Clin. Exp. Immunol. 167, 206-215.
14. Byrd, J., and Bresalier, R. (2004) Mucins and mucin binding proteins in colorectal cancer. Cancer Metastasis Rev. 23, 77-99. (Pubitemid 38221597)
15. Nakayama, T., Watanabe, M., Katsumata, T., Teramoto, T., and Kitajima, M. (1995) Expression of Sialyl Lewisa as a new prognostic factor for patients with advanced colorectal carcinoma. Cancer 75, 2051-2056.
16. Kannagi, R. (2003) Molecular mechanism for cancer-associated induction of sialyl Lewis X and sialyl Lewis A expression-The Warburg effect revisited. Glycoconjugate J. 20, 353-364. (Pubitemid 39024043)
17. Koike, T., Kimura, N., Miyazaki, K., Yabuta, T., Kumamoto, K., Takenoshita, S., Chen, J., Kobayashi, M., Hosokawa, M., Taniguchi, A., Kojima, T., Ishida, N., Kawakita, M., Yamamoto, H., Takematsu, H., Suzuki, A., Kozutsumi, Y., and Kanangi, R. (2004) Hypoxia induces adhesion molecules on cancer cells: A missing link between Warburg effect and induction of selectin-ligand carbohydrates. Proc. Natl. Acad. Sci. U.S.A. 101, 8132-8137. (Pubitemid 38698066)
18. Hamilton, W. B., Helling, F., Lloyd, K. O., and Livingston, P. O. (1993) Ganglioside expression on human malignant melanoma assessed by quantitative immune thin-layer chromatography. Int. J. Cancer 53, 566-573. (Pubitemid 23069265)
19. Birklé, S., Zeng, G., Gao, L., Yu, R. K., and Aubry, J. (2003) Role of tumor-associated gangliosides in cancer progression. Biochem. Mol. Biol. 85, 455-463. (Pubitemid 36626016)
20. Miyoshi, E., Moriwaki, K., and Nakagawa, T. (2008) Biological Function of Fucosylation in Cancer Biology. J. Biochem. 143, 725-729. (Pubitemid 351918934)
21. Moriwaki, K. (2010) Fucosylation and gastrointestinal cancer. WJH, 2, 151.
22. Misonou, Y., Shida, K., Korekane, H., Seki, Y., Noura, S., Ohue, M., and Miyamoto, Y. (2009) Comprehensive Clinico-Glycomic Study of 16 Colorectal Cancer Specimens: Elucidation of Aberrant Glycosylation and Its Mechanistic Causes in Colorectal Cancer Cells. J. Proteome Res. 8, 2990-3005.
23. Balog, C. I. A., Stavenhagen, K., Fung, W. L. J., Koeleman, C. A., McDonnell, L. A., Verhoeven, A., Mesker, W. E., Tollenaar, R. A. E. M., Deelder, A. M., and Wuhrer, M. (2012) N-glycosylation of colorectal cancer tissues: A liquid chromatography and mass spectrometry-based investigation. Mol. Cell. Proteomics 11, 571-585.
24. Ruhaak, L. R., Steenvoorden, E., Koeleman, C. A. M., Deelder, A. M., and Wuhrer, M. (2010) 2-Picoline-borane: A non-toxic reducing agent for oligosaccharide labeling by reductive amination. Proteomics 10, 2330- 2336.
25. Selman, M. H. J., Hemayatkar, M., Deelder, A. M., and Wuhrer, M. (2011) Cotton HILIC SPE microtips for microscale purification and enrichment of glycans and glycopeptides. Anal. Chem. 83, 2492-2499.
26. Holgersson, J., Strömberg, N., and Breimer, M. E. (1988) Glycolipids of human large intestine: difference in glycolipid expression related to anatomical localization, epithelial/non-epithelial tissue and the ABO, Le and Se phenotypes of the donors. Biochimie 70, 1565-1574. (Pubitemid 19039628)
27. Korekane, H., Tsuji, S., Noura, S., Ohue, M., Sasaki, Y., Imaoka, S., and Miyamoto, Y. (2007) Novel fucogangliosides found in human colon adenocarcinoma tissues by means of glycomic analysis. Anal. Biochem. 364, 37-50. (Pubitemid 46497950)
28. Stroud, M. R., Handa, K., Salyan, M. E. K., Ito, K., Levery, S. B., Hakomori, S.-i., Reinhold, B. B., and Reinhold, V. N. (1996) Monosialogangliosides of human myelogenous leukemia HL60 cells and normal human leukocytes. 1. Separation of E-selectin binding from nonbinding gangliosides, and absence of sialosyl-lex having tetraosyl to octaosyl core. Biochemistry 35, 758-769.
29. Cheresh, D. A., A. P. Varki, N. M. Varki, W. B. Stallcup, J. Levine, and R. A. Reisfeld. (1984) A monoclonal antibody recognizes an O-acylated sialic acid in a human melanoma-associated ganglioside. J. Biol. Chem. 259, 7453-7459.
30. Schauer, R., Srinivasan, G. V., Wipfler, D., Kniep, B., and Schwartz-Albiez, R. (2011). O-Acetylated Sialic Acids and Their Role in Immune Defense, p. 525-548. In A. M. Wu (ed.), The molecular immunology of complex carbohydrates-3. Springer US. Advances in Experimental Medicine and Biology. Springer US.
31. Wuhrer, M., Grimm, C., Dennis, R. D., Idris, M. A., and Geyer, R. (2004) The parasitic trematode Fasciola hepatica exhibits mammalian-type glycolipids as well as Gal(β1-6)Gal-terminating glycolipids that account for cestode serological cross-reactivity. Glycobiology 14, 115-126. (Pubitemid 38263096)
32. Ito, M., and Yamagata, T. (1989) Purification and characterization of glycosphingolipid- specific endoglycosidases (endoglycoceramidases) from a mutant strain of Rhodococcus sp. Evidence for three molecular species of endoglycoceramidase with different specificities. J. Biol. Chem. 264, 9510-9519.
33. Wuhrer, M., Deelder, A. M., and van der Burgt, Y. E. (2011) Mass spectrometric glycan rearrangements. Mass Spectrom. Rev. 30, 664-680.
34. Jansen, J. J., Hoefsloot, H. C., van der Greef, J., Timmerman, M. E., and Smilde, A. K. (2005) Multilevel component analysis of time-resolved metabolic fingerprinting data. Anal. Chim. Acta 530, 173-183. (Pubitemid 40215740)
35. Ruhaak, L. R., Zauner, G., Huhn, C., Bruggink, C., Deelder, A. M., and Wuhrer, M. (2010) Glycan labeling strategies and their use in identification and quantification. Anal. Bioanal. Chem. 397, 3457-3481.
36. Breimer, M. E., Hansson, G. C., Karlsson, K.-A., Larson, G., and Leffler, H. (2012) Glycosphingolipid composition of epithelial cells isolated along the villus axis of small intestine of a single human individual. Glycobiology 22, 1721-1730.
37. Schiffmann, L., Schwarz, F., Linnebacher, M., Prall, F., Pahnke, J., Krentz, H., Vollmar, B., and Klar, E. (2012) A novel sialyl LeX expression score as a potential prognostic tool in colorectal cancer. WJSO 10, 95.
38. Hakomori, S., Nudelman, E., Levery, S. B., and Kannagi, R. (1984) Novel fucolipids accumulating in human adenocarcinoma. I. Glycolipids with di- or trifucosylated type 2 chain. J. Biol. Chem. 259, 4672-4680. (Pubitemid 14131378)
39. Fukushi, Y., Nudelman, E., Levery, S. B., Hakomori, S., and Rauvala, H. (1984) Novel fucolipids accumulating in human adenocarcinoma. III. A hybridoma antibody (FH6) defining a human cancer-associated difucoganglioside (VI3NeuAcV3III3Fuc2nLc6). J. Biol. Chem. 259, 10511- 10517. (Pubitemid 14064152)
40. Nudelman, E. D., Levery, S. B., Stroud, M. R., Salyan, M. E., Abe, K., and Hakomori, S. (1988) A novel tumor-associated, developmentally regulated glycolipid antigen defined by monoclonal antibody ACFH-18. J. Biol. Chem. 263, 13942-13951.
41. Stroud, M. R., Handa, K., Ito, K., Salyan, M. E. K., Fang, H., Levery, S. B., Hakamori, S., Reinhold, B. B., and Reinhold, V. N. (1995) Myeloglycan, a series of E-selectin-binding polylactosaminolipids found in normal human leukocytes and myelocytic leukemia HL60 cells. Biochem. Biophys. Res. Commun. 209, 777-787.
42. Stroud, M. R., Handa, K., Salyan, M. E. K., Ito, K., Levery, S. B., Hakomori, S.-i., Reinhold, B. B., and Reinhold, V. N. (1996) Monosialogangliosides of human myelogenous leukemia HL60 cells and normal human leukocytes. 2. Characterization of E-selectin binding fractions, and structural requirements for physiological binding to E-selectin. Biochemistry 35, 770-778.
43. Ravindranath, M. H., Muthugounder, S., and Presser, N. (2008) Ganglioside signatures of primary and nodal metastatic melanoma cell lines from the same patient. Melanoma Res. 18, 47-55. (Pubitemid 351628056)
44. Shen, Y., Kohla, G., Lrhorfi, A. L., Sipos, B., Kalthoff, H., Gerwig, G. J., Kamerling, J. P., Schauer, R., and Tiralongo, J. (2004) O-acetylation and de-O-acetylation of sialic acids in human colorectal carcinoma. Eur. J. Biochem. 271, 281-290. (Pubitemid 38130456)
45. Corfield, A., Myerscough, N., Warren, B., Durdey, P., Paraskeva, C., and Schauer, R. (1999) Reduction of sialic acid O-acetylation in human colonic mucins in the adenoma-carcinoma sequence. Glycoconjugate J. 16, 307-317. (Pubitemid 29486318)
46. Robbe, C., Capon, C., Maes, E., Rousset, M., Zweibaum, A., Zanetta, J.-P., and Michalski, J.-C. (2003) Evidence of regio-specific glycosylation in human intestinal mucins: Presence of an acidic gradient along the intestinal tract. J. Biol. Chem. 278, 46337-46348. (Pubitemid 37452204)
47. Kohla, G., Stockfleth, E., and Schauer, R. (2002) Gangliosides with Oacetylated sialic acids in tumors of neuroectodermal origin. Neurochem. Res. 27, 583-592.
48. Vavasseur, F., Dole, K., Yang, J., Matta, K. L., Myerscough, N., Corfield, A., Paraskeva, C., and Brockhausen, I. (1994) O-glycan biosynthesis in human colorectal adenoma cells during progression to cancer. Eur. J. Biochem. 222, 415-424. (Pubitemid 24204910)
49. Izawa, M., Kumamoto, K., Mitsuoka, C., Kanamori, A., Ohmori, K., Ishida, H., Nakamura, S., Kurata-Miura, K., Sasaki, K., Nishi, T., and Kannagi, R. (2000) Expression of sialyl 6-sulfo Lewis X is inversely correlated with conventional sialyl Lewis X expression in human colorectal cancer. Cancer Res. 60, 1410-1416. (Pubitemid 30152015)
50. Yusa, A., Miyazaki, K., Kimura, N., Izawa, M., and Kannagi, R. (2010) Epigenetic silencing of the sulfate transporter gene DTDST induces sialyl Lewis x expression and accelerates proliferation of colon cancer cells. Cancer Res. 70, 4064-4073.
51. Tei, K., Kawakami-Kimura, N., Taguchi, O., Kumamoto, K., Higashiyama, S., Taniguchi, N., Toda, K., Kawata, R., Hisa, Y., and Kannagi, R. (2002) Roles of cell adhesion molecules in tumor angiogenesis induced by cotransplantation of cancer and endothelial cells to nude rats. Cancer Res. 62, 6289-6296. (Pubitemid 35244483)
52. Chandrasekaran, E. V., Xue, J., Piskorz, C., Locke, R., Tóth, K., Slocum, H., and Matta, K. (2007) Potential tumor markers for human gastric cancer: An elevation of glycan:sulfotransferases and a concomitant loss of α1, 2- fucosyltransferase activities. J. Cancer Res. Clin. Oncol. 133, 599-611. (Pubitemid 47077051)
53. Siddiqui, B., Whitehead, J. S., and Kim, Y. S. (1978) Glycosphingolipids in human colonic adenocarcinoma. J. Biol. Chem. 253, 2168-2175. (Pubitemid 8350177)
54. Morichika, H., Hamanaka, Y., Tai, T., and Ishizuka, I. (1996) Sulfatides as a predictive factor of lymph node metastasis in patients with colorectal adenocarcinoma. Cancer 78, 43-47. (Pubitemid 26189903)
55. Shida, K., Misonou, Y., Korekane, H., Seki, Y., Noura, S., Ohue, M., Honke, K., and Miyamoto, Y. (2009) Unusual accumulation of sulfated glycosphingolipids in colon cancer cells. Glycobiology 19, 1018-1033.
56. Brockhausen, I., and Kuhns, W. (1997) Role and metabolism of glycoconjugate sulfation. Trends Glycosci. Glycotechnol. 9, 379-398.
57. Ideo, H., Seko, A., and Yamashita, K. (2005) Galectin-4 binds to sulfated glycosphingolipids and carcinoembryonic antigen in patches on the cell surface of human colon adenocarcinoma cells. J. Biol. Chem. 280, 4730-4737. (Pubitemid 40288643)
58. Kovbasnjuk, O., Mourtazina, R., Baibakov, B., Wang, T., Elowsky, C., Choti, M. A., Kane, A., and Donowitz, M. (2005) The glycosphingolipid globotriaosylceramide in the metastatic transformation of colon cancer. Proc. Natl. Acad. Sci. U.S.A. 102, 19087-19092. (Pubitemid 43049570)
59. Lingwood, C. A. (1999) Verotoxin/globotriaosyl ceramide recognition: Angiopathy, angiogenesis and antineoplasia. Biosci. Rep. 19, 345-354. (Pubitemid 30169335)
60. Desselle, A., Chaumette, T., Gaugler, M.-H., Cochonneau, D., Fleurence, J., Dubois, N., Hulin, P., Aubry, J., Birklé, S., Paris, F., and Addison, C. L. (2012) Anti-Gb3 monoclonal antibody inhibits angiogenesis and tumor development. PLoS ONE 7, e45423.
61. Hakomori, S. (1985) Aberrant glycosylation in cancer cell membranes as focused on glycolipids: overview and perspectives. Cancer Res. 45, 2405-2414. (Pubitemid 15024398)
62. Heimburg-Molinaro, J., Lum, M., Vijay, G., Jain, M., Almogren, A., and Rittenhouse-Olson, K. (2011) Cancer vaccines and carbohydrate epitopes. Vaccine 29, 8802-8826.
63. Shibuya, H., Hamamura, K., Hotta, H., Matsumoto, Y., Nishida, Y., Hattori, H., Furukawa, K., Ueda, M., and Furukawa, K. (2012) Enhancement of malignant properties of human osteosarcoma cells with disialyl gangliosides GD2/GD3. Cancer Sci. 103, 1656-1664.
64. Furukawa, K., Hamamura, K., Ohkawa, Y., Ohmi, Y., and Furukawa, K. (2012) Disialyl gangliosides enhance tumor phenotypes with differential modalities. Glycoconjugate J. 29, 579-584.
65. Nudelman, E., Fukushi, Y., Levery, S. B., Higuchi, T., and Hakomori, S. (1986) Novel fucolipids of human adenocarcinoma: disialosyl Lea antigen (III4FucIII6NeuAcIV3NeuAcLc4) of human colonic adenocarcinoma and the monoclonal antibody (FH7) defining this structure. J. Biol. Chem. 261, 5487-5495. (Pubitemid 17204364)
66. Miyazaki, K., Ohmori, K., Izawa, M., Koike, T., Kumamoto, K., Furukawa, K., Ando, T., Kiso, M., Yamaji, T., Hashimoto, Y., Suzuki, A., Yoshida, A., Takeuchi, M., and Kannagi, R. (2004) Loss of disialyl Lewis a, the ligand for lymphocyte inhibitory receptor sialic acid-binding immunoglobulinlike lectin-7 (Siglec-7) associated with increased sialyl Lewis a expression on human colon cancers. Cancer Res. 64, 4498-4505. (Pubitemid 38856921)
67. Tsuchida, A., Okajima, T., Furukawa, K., Ando, T., Ishida, H., Yoshida, A., Nakamura, Y., Kannagi, R., Kiso, M., and Furukawa, K. (2003) Synthesis of Disialyl Lewis a (Lea) Structure in colon cancer cell lines by a sialyltransferase, ST6GalNAc VI, responsible for the synthesis of α-series gangliosides. J. Biol. Chem. 278, 22787-22794. (Pubitemid 36830340)